X

We aim to transform protein production to allow universal access to biologics.

AREAS OF FOCUS

Animal Health

20 years’ experience in the development and production of animal vaccines.
200 molecules successfully produced in collaboration with public and private partners, including multiple international pharmaceutical companies.
FatrovaxRHD, first vaccine produced in CrisBio® received marketing authorization in the European Union and United Kingdom in Q3.

Learn more

Human Health

Building on experience in animal health, Algenex is expanding the production of proteins into human health to fully exploit the potential of its technology platforms

Learn more

Biocomponents

Algenex has an established track record as a producer of antigens proteins for the human and animal diagnostic and therapeutic markets and has also demonstrated the applicability of its technology platform CrisBio® to on-demand production of growth factors, enzymes and cytokines.

Learn more

LATEST NEWS

News

18/11
Company CrisBio

Algenex y Werfen renuevan su acuerdo para producir test de d...

Algenex y Werfen renuevan su acuerdo para producir test de d...
Learn more

News

10/11
Company CrisBio

Algenex, reconocida como mejor compañía europea en los Anima...

Algenex SL, reconocida como mejor compañía europea en los Animal Health Awards 2021
Learn more

News

28/10
Company CrisBio

Commercial Adoption of Herdscreen® ASFV Antibody Test in Eur...

Commercial Adoption of Herdscreen® ASFV Antibody Test in Eur...
Learn more